Cargando…
外泌体PD-L1在非小细胞肺癌免疫治疗的研究进展
Cancer immunotherapy is increasingly popular in the field of cancer treatment, and related research is emerging. For patients with non-small cell lung cancer (NSCLC), in recent years, immune checkpoint inhibitors (ICIs) represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549428/ https://www.ncbi.nlm.nih.gov/pubmed/36172735 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.33 |